Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × Resistance Training × 90 days × Clear all

Sponsor

Conditions

Motor Activity 4 Pancreatic Neoplasms 3 Obesity 3 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Skin Neoplasms 1 Sarcopenia 1 Renal Insufficiency, Chronic 1 Rehabilitation Exercise 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Overweight 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Inflammation 1 Hematopoietic and Lymphatic System Neoplasm 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

venetoclax 104 Azacitidine 83 Cytarabine 71 Specimen Handling 48 fludarabine 43 Biopsy 32 Daunorubicin 29 Cyclophosphamide 29 Decitabine 27 fludarabine phosphate 24 Injections 22 Idarubicin 22 Granulocyte Colony-Stimulating Factor 22 Whole-Body Irradiation 18 Stem Cell Transplantation 18 CPX-351 16 Busulfan 16 gilteritinib 15 decitabine and cedazuridine drug combination 15 Mycophenolic Acid 14 Cladribine 14 Melphalan 13 Filgrastim 13 Tacrolimus 11 Mitoxantrone 11 Magnetic Resonance Spectroscopy 10 revumenib 9 Gemtuzumab 9 olutasidenib 8 X-Rays 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡